Classification | Index | Grouping | Base value | Intermediate value | Terminal value |
T lymphocyte | CD3+ (%) | Experience group | 65.10 ± 12.97 | 62.67 ± 10.21 | 59.00 ± 9.94 |
control group | 64.13 ± 8.98 | 55.40 ± 9.81 | 59.00 ± 10.43 | ||
CD4+ (%) | experience group | 33.20 ± 7.58 | 27.50 ± 3.89 | 26.89 ± 4.17* | |
control group | 36.25 ± 7.49 | 29.60 ± 5.03 | 31.50 ± 4.76 | ||
CD8+ (%) | experience group | 29.5 ± 7.82 | 33.00 ± 8.46 | 29.67 ± 8.28 | |
control group | 24.63 ± 5.04 | 22.00 ± 6.82 | 23.50 ± 6.83 | ||
CD4+/CD8+ | experience group | 1.03 ± 0.15 | 0.87 ± 0.23* | 0.96 ± 0.23 | |
control group | 1.40 ± 0.40 | 1.22 ± 0.33 | 1.25 ± 0.28 | ||
NK cells | CD3 - CD16+ or CD56+ (%) | experience group | 20.40 ± 11.38 | 27.33 ± 8.19 | 30.56 ± 8.69* |
control group | 19.63 ± 8.83 | 27.75 ± 6.90 | 24.00 ± 5.00 |